Results 201 to 210 of about 6,488,856 (287)

Antiresorptive therapy influence on peri‐implant diseases: Clinical implications and osteoimmunological perspectives

Periodontology 2000, EarlyView.
Abstract Background/Aim Antiresorptive therapy represents a cornerstone in the management of osteoporosis and cancer‐related bone disease through suppression of osteoclast‐mediated bone resorption. As implant therapy becomes more common in aging populations, clinicians increasingly encounter patients receiving these medications, thus making their ...
Emilio A. Cafferata, Frank Schwarz, Reinhard Gruber   +2 more
wiley   +1 more source

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026. [PDF]

Cardiovasc Interv Ther
Ozaki Y, Tobe A, Onuma Y, Miyashita K, Kobayashi Y, Amano T, Yamaji K, Ishii H, Muramatsu T, Ismail TF, Kohsaka S, Nakagawa Y, Morino Y, Uemura S, Tsujita K, Shinke T, Ako J, Yajima J, Maekawa Y, Shite J, Igarashi Y, Shiode N, Okamura A, Ogawa T, Yamaguchi J, Tamura T, Tsuji T, Hayashida K, Sugano T, Okura H, Okayama H, Kawaguchi K, Zen K, Takahashi S, Nakazato K, Suematsu N, Hironaga K, Matoba T, Iida O, Ishihara M, Ohta M, Harada M, Ozaki R, Izawa H, Murohara T, Ueno T, Nakamura M, Ikari Y, Serruys PW, Kozuma K, Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT).   +50 more
europepmc   +1 more source

Systemic pirfenidone treatment fails to mitigate fibrosis and compromises functional recovery in a porcine model of volumetric muscle loss

Experimental Physiology, EarlyView.
Abstract Repurposing clinically approved antifibrotic agents presents a potential near‐term therapeutic strategy to mitigate the extensive fibrotic scarring that follows severe volumetric muscle loss (VML) injury and inhibits functional recovery. We hypothesized that daily oral administration of pirfenidone, an FDA‐approved antifibrotic, would mitigate
Jessica M. Motherwell, Ondine Eken, Claudia E. Hernandez, Christopher L. Dearth, Stephen M. Goldman   +4 more
wiley   +1 more source

Assessment of Left Ventricular Systolic Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Anterior Wall ST-Segment Elevation Myocardial Infarction After 48 Hours in the Cardiac Emergency. [PDF]

Cureus
Raees A, Raees A, Chattha AT, Flogaitis I.   +3 more
europepmc   +1 more source

Running‐based rehabilitation does not improve muscle function after volumetric muscle loss despite improving hindlimb weight‐bearing asymmetry in mice

Experimental Physiology, EarlyView.
Abstract Volumetric muscle loss (VML) is a traumatic skeletal muscle injury characterized by chronic functional impairments in the affected muscle and adjacent uninjured bone. Rehabilitative strategies aimed at restoring limb function following VML, including voluntary running, have shown limited efficacy and in some cases have been detrimental.
Angela S. Bruzina, Molly R. Weberg, Ryan J. Willoughby, Gordon L. Warren, Jarrod A. Call, Sarah M. Greising   +5 more
wiley   +1 more source

Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarction. [PDF]

Open Heart
Laffan J, Gao H, Street A, Coughlan JJ, Armstrong R, Maree A, Blake G, Kearney P, Crowley J, Kiernan TJ, McCreery C, Aleong G, Peace A, Kennedy M, Byrne RA.   +14 more
europepmc   +1 more source

The multicellular environment of the re‐entrant circuit in post‐myocardial infarction ventricular tachycardia: Beyond fibrosis

The Journal of Physiology, EarlyView.
Abstract figure legend Schematic overview of the temporal evolution of the post‐myocardial infarction substrate leading to ventricular tachycardia. Acute ischaemic injury initiates metabolic and electrophysiological disruption, followed by progressive inflammatory, fibrotic and structural remodelling within the infarct border zone.
Mohammed Obeidat, Jaffar Al‐Sheikhli, Andrew M. Blanks, Joseph Mayer, Nicolas Lellouche, Tarvinder Dhanjal, Christopher O'Shea   +6 more
wiley   +1 more source

Missing-data-aware machine learning prediction of in-hospital major adverse cardiovascular events after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. [PDF]

Sci Rep
Mirzohreh ST, Roshanravan N, Suleymanov T, Makarov DM, Zargarzadeh A, Javanshir E, Separham A, Ghaffari A, Motlagh PM, Ghaffari S, Jouyban A.   +10 more
europepmc   +1 more source

Primary percutaneous coronary intervention

, 2017
Toutouzas, K., Kaitozis, O., Tousoulis, D.   +2 more
openaire   +1 more source

Translating cardiovascular ion channel and Ca2+ signalling mechanisms into therapeutic insights

The Journal of Physiology, EarlyView.
Abstract figure legend This white paper integrates mechanistic discoveries across ion channel biology, Ca2+ signalling and multiscale cardiovascular physiology to highlight new opportunities for accelerating research and guiding next‐generation therapies. Printed with permission from ®Anita Impagliazzo Medical Illustration. [Correction added on 2 March
Silvia Marchianò, Miguel Martín‐Aragón Baudel, Charlotte E. R. Smith, Gonzalo Hernandez Hernandez, Donald M. Bers, Patrick M. Boyle, Dobromir Dobrev, Shanna Hamilton, Osama F. Harraz, Na Li, Thomas A. Longden, William E. Louch, Madeline Nieves‐Cintron, Matthew A. Nystoriak, Walter Lee Murfee, Przemysław B. Radwański, Swapnil K. Sonkusare, Manuel F. Navedo, Eleonora Grandi   +18 more
wiley   +1 more source